ET-01 in Subjects With Lateral Canthal Lines, LCL-209

NCT03912805 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Lateral Canthal Lines, LCL
Crow's Feet

Interventions

BIOLOGICAL: botulinum toxin, Type A
BIOLOGICAL: Vehicle

Sponsor

Eirion Therapeutics Inc.